These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 33634845

  • 21. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
    Siudak Z, Dziewierz A, Rakowski T, Żmudka K, Legutko J, Bartuś S, Dragan J, Zasada W, Tokarek T, Kułaga T, Partyka Ł, Dudek D.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):436-42. PubMed ID: 24038740
    [Abstract] [Full Text] [Related]

  • 22. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Catheter Cardiovasc Interv; 2022 Mar 15; 99(4):1022-1037. PubMed ID: 34962070
    [Abstract] [Full Text] [Related]

  • 23. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
    Sim HW, Thong EH, Djohan AH, Chen JZ, Ser JS, Loh PH, Lee CH, Chan MY, Low AF, Tay EL, Chan KH, Tan HC, Loh JP.
    Cardiovasc Revasc Med; 2022 Feb 15; 35():98-103. PubMed ID: 33893053
    [Abstract] [Full Text] [Related]

  • 24. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Stehli J, Martin C, Brennan A, Dinh DT, Lefkovits J, Zaman S.
    J Am Heart Assoc; 2019 May 21; 8(10):e012161. PubMed ID: 31092091
    [Abstract] [Full Text] [Related]

  • 25. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial.
    Gabani R, Spione F, Arevalos V, Grima Sopesens N, Ortega-Paz L, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jiménez-Quevedo P, Diletti R, Pineda J, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, Bastos-Fernandez G, Iñiguez A, Serra A, Escaned J, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Bordes P, Tebaldi M, Biscaglia S, Al-Shaibani S, Romaguera R, Gomez-Hospital JA, Rodes-Cabau J, Serruys PW, Sabaté M, Brugaletta S.
    JACC Cardiovasc Interv; 2022 Oct 10; 15(19):1965-1973. PubMed ID: 36008267
    [Abstract] [Full Text] [Related]

  • 26. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, Jensen UJ, Tödt T, Götberg M, James SK.
    J Am Coll Cardiol; 2014 Jul 08; 64(1):16-24. PubMed ID: 24998123
    [Abstract] [Full Text] [Related]

  • 27. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.
    Roe MT, Chen AY, Cannon CP, Rao S, Rumsfeld J, Magid DJ, Brindis R, Klein LW, Gibler WB, Ohman EM, Peterson ED, CRUSADE and ACTION-GWTG Registry Participants.
    Circ Cardiovasc Qual Outcomes; 2009 Sep 08; 2(5):414-20. PubMed ID: 20031871
    [Abstract] [Full Text] [Related]

  • 28. The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry.
    Holroyd EW, Sirker A, Kwok CS, Kontopantelis E, Ludman PF, De Belder MA, Butler R, Cotton J, Zaman A, Mamas MA, British Cardiovascular Intervention Society and National Institute of Cardiovascular Outcomes Research.
    JACC Cardiovasc Interv; 2017 Jul 10; 10(13):1283-1292. PubMed ID: 28683933
    [Abstract] [Full Text] [Related]

  • 29. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Yun KH, Xu K, Kirtane AJ, Stone GW, Maehara A.
    Am J Cardiol; 2015 Apr 01; 115(7):860-6. PubMed ID: 25661569
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction.
    Murakami T, Sakakura K, Taniguchi Y, Yamamoto K, Tsukui T, Seguchi M, Jinnouchi H, Wada H, Fujita H.
    Cardiovasc Interv Ther; 2022 Apr 01; 37(2):293-303. PubMed ID: 33884579
    [Abstract] [Full Text] [Related]

  • 31. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Medicine (Baltimore); 2021 Dec 10; 100(49):e28214. PubMed ID: 34889307
    [Abstract] [Full Text] [Related]

  • 32. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, Lemesle G, Motreff P, Popovic B, Khalife K, Labèque JN, Perret T, Le Ray C, Orion L, Jouve B, Blanchard D, Peycher P, Silvain J, Steg PG, Goldstein P, Guéret P, Belle L, Aissaoui N, Ferrières J, Schiele F, Danchin N, USIK, USIC 2000, and FAST-MI investigators.
    Circulation; 2017 Nov 14; 136(20):1908-1919. PubMed ID: 28844989
    [Abstract] [Full Text] [Related]

  • 33. Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: A meta-analysis.
    Ando T, Takagi H, Grines CL.
    J Interv Cardiol; 2017 Aug 14; 30(4):309-317. PubMed ID: 28573650
    [Abstract] [Full Text] [Related]

  • 34. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2019 May 14; 284():102-109. PubMed ID: 30877937
    [Abstract] [Full Text] [Related]

  • 35. Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J-PCI Registry.
    Inohara T, Kohsaka S, Yamaji K, Iida O, Shinke T, Sakakura K, Ishii H, Amano T, Ikari Y.
    J Am Heart Assoc; 2022 Aug 16; 11(16):e025728. PubMed ID: 35946472
    [Abstract] [Full Text] [Related]

  • 36. Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.
    Fath-Ordoubadi F, Spaepen E, El-Omar M, Fraser DG, Khan MA, Neyses L, Danzi GB, Roguin A, Paunovic D, Mamas MA.
    PLoS One; 2014 Aug 16; 9(2):e88577. PubMed ID: 24551120
    [Abstract] [Full Text] [Related]

  • 37. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.
    JACC Cardiovasc Interv; 2015 Jan 16; 8(1 Pt B):189-197. PubMed ID: 25616924
    [Abstract] [Full Text] [Related]

  • 38. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 16; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 39. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY, Kang TS, Rha SW, Choi BG, Park SH, Jeong MH.
    Coron Artery Dis; 2018 Aug 16; 29(5):416-422. PubMed ID: 29708887
    [Abstract] [Full Text] [Related]

  • 40. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Yu J, Mehran R, Baber U, Ooi SY, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Brodie BR, Stuckey TD, Maehara A, Xu K, Ben-Yehuda O, Kirtane AJ, Stone GW.
    Circ Cardiovasc Interv; 2017 Feb 16; 10(2):. PubMed ID: 28193677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.